CN Patent

CN106831787B — 用作布鲁顿酪氨酸激酶抑制剂的化合物及其制备方法和应用

Assigned to Chengdu Beite Pharmaceutical Co ltd · Expires 2018-10-23 · 8y expired

What this patent protects

本发明提供了具有式(Ⅰ)所示结构的化合物，或其异构体、药学上可接受的溶剂化物、盐，用作布鲁顿酪氨酸激酶抑制剂，其对于BTK具有较高的抑制活性，同时具有较小的不良反应。

USPTO Abstract

本发明提供了具有式(Ⅰ)所示结构的化合物，或其异构体、药学上可接受的溶剂化物、盐，用作布鲁顿酪氨酸激酶抑制剂，其对于BTK具有较高的抑制活性，同时具有较小的不良反应。

Drugs covered by this patent

Patent Metadata

Patent number
CN106831787B
Jurisdiction
CN
Classification
—
Expires
2018-10-23
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Beite Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.